within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BA02_ImmunoglobulinsNormalHumanForInt;

model ImmunoglobulinsNormalHumanForInt
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 6.805555555555555e-08,
    adminDuration = 600,
    adminMass = 400 / 1000000,
    adminCount = 1,
    Vd = 0.0045,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0024,
    k12 = 7.388888888888888e-08,
    k21 = 7.388888888888888e-08);

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>ImmunoglobulinsNormalHumanForIntravascularAdm</td></tr><tr><td>ATC code:</td><td>J06BA02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Normal human immunoglobulin for intravascular administration is a purified preparation of immunoglobulin G (IgG) derived from pooled human plasma. It is used for replacement therapy in primary immunodeficiency syndromes, as well as in certain autoimmune and infectious diseases. The drug is widely used and is approved for clinical use in many countries today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following intravenous administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J06BA02 folded in (Drugs.ATC removed)</li><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ImmunoglobulinsNormalHumanForInt;
